Canadians must wait 41.7 weeks (on average) to receive medically necessary elective orthopaedic surgery.
Survey says seven in 10 Canadians are ready for virtual doctor appointments.
Hospitals in Switzerland compete with one another for patients.
Review board’s new reference countries have more limited access to new and innovative drugs.
The original OHIP+ provided limited coverage to a population that largely didn’t need assistance.
U.S. pharmaceutical innovation has been disproportionately funded by U.S. consumers of patented drugs.
In Switzerland, the health-care system features managed competition among insurance companies and health-care providers.
In most countries with universal health care, patients share the cost of treatment—surgical or pharmaceutical.
Unlike Canadians, Germans do not face long wait times for health care.
Insurance companies are the principal beneficiaries of Ontario’s new publicly-funded pharmacare program.